Skip to content

Psychopharmacology

ISSN 1432-2072, 0033-3158

637 papers in the library · 20,322 citations · publishing 1971-2026

Papers

Sort Most recent Most cited

Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeys.

Psychopharmacology July 1, 2014 Kevin B Freeman, Jennifer E Naylor, Thomas E Prisinzano et al.

Drugs can function as punishers. However, work on the study of drugs as punishers is limited, as is the range of compounds known to function as punishers. Kappa opioid agonists, which have received much experimental attention as potential therapeutics for drug abuse, reportedly produce aversive effects. However, kappa agonists have yet to be tested as punishers of behavior. The goal of the...

Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism.

Psychopharmacology June 2014 Mohini Ranganathan, R Andrew Sewell, Michelle Carbuto et al.

A family history (FH) of alcoholism accounts for approximately 50% of the risk of developing alcohol problems. Several lines of preclinical evidence suggest that brain cannabinoid receptor (CB1R) function may mediate the effects of alcohol and risk for developing alcoholism including the observations that reduced CB1R function decreases alcohol-related behaviors and enhanced CB1R function...

Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of 'schizophrenia-like' behaviour in the rat.

Psychopharmacology June 2014 Philip L R Gaskin, Stephen P H Alexander, Kevin C F Fone

Schizophrenia is a debilitating disorder comprising positive, negative and cognitive deficits with a poorly defined neurobiological aetiology; therefore, animal models with greater translational reliability are essential to develop improved therapies. This study combines two developmental challenges in rats, neonatal phencyclidine (PCP) injection and subsequent rearing in social isolation from...

MDMA alters emotional processing and facilitates positive social interaction

Psychopharmacology April 12, 2014 Margaret C. Wardle, Harriet de Wit 97 citations

±3,4-Methylenedioxymethamphetamine (MDMA, “ecstasy”) produces “prosocial” effects, such as feelings of empathy and closeness, thought to be important to its abuse and its value in psychotherapy. However, it is not fully understood how MDMA alters basic emotional processes to produce these effects, or whether it produces corresponding changes in actual social behavior. Here, we examined how MDMA...

Neural responses to subliminally presented cannabis and other emotionally evocative cues in cannabis-dependent individuals.

Psychopharmacology April 2014 Reagan R Wetherill, Anna Rose Childress, Kanchana Jagannathan et al.

Addiction theories posit that drug-related cues maintain and contribute to drug use and relapse. Indeed, our recent study in cocaine-dependent patients demonstrated that subliminally presented cocaine-related stimuli activate reward neurocircuitry without being consciously perceived. Activation of reward neurocircuitry may provoke craving and perhaps prime an individual for subsequent...

MDMA effects consistent across laboratories

Psychopharmacology March 15, 2014 M. Kirkpatrick, Matthew J. Baggott, John Mendelson et al. 78 citations

Several laboratories have conducted placebo-controlled drug challenge studies with 3,4-methylenedioxymethamphetamine (MDMA), providing a unique source of data to examine the reliability of the acute effects of the drug across subject samples and settings. We examined the subjective and physiological responses to the drug across three different laboratories and investigated the influence of...

Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.

Psychopharmacology March 1, 2014 Amy J. Eshleman, Michael J Forster, Katherine M. Wolfrum et al. 72 citations

Psychoactive-substituted phenethylamines 2,5-dimethoxy-4-chlorophenethylamine (2C-C); 2,5-dimethoxy-4-methylphenethylamine (2C-D); 2,5-dimethoxy-4-ethylphenethylamine (2C-E); 2,5-dimethoxy-4-iodophenethylamine (2C-I); 2,5-dimethoxy-4-ethylthiophenethylamine (2C-T-2); and 2,5-dimethoxy-4-chloroamphetamine (DOC) are used recreationally and may have deleterious side effects. This study compares...

DOI: 10.1007/s00213-013-3303-6 (opens in new tab) Full text (opens in new tab) Phenethylamines Psychoactive compounds Drugs Substances +12

Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats.

Psychopharmacology February 2014 Torbjörn U C Järbe, Brian J LeMay, Aneetha Halikhedkar et al.

The "subjective high" from marijuana ingestion is likely due to Δ(9)-tetrahydrocannabinol (THC) activating the central cannabinoid receptor type 1 (CB1R) of the endocannabinoid signaling system. THC is a weak partial agonist according to in vitro assays, yet THC mimics the behavioral effects induced by more efficacious cannabinergics. This distinction may be important for understanding...

Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).

Psychopharmacology February 2014 Lynn Taurah, Chris Chandler, Geoff Sanders

Ecstasy (3,4-methylenedioxymethamphetamine, MDMA) is a worldwide recreational drug of abuse. Unfortunately, the results from human research investigating its psychological effects have been inconsistent. The present study aimed to be the largest to date in sample size and 5HT-related behaviors; the first to compare present ecstasy users with past users after an abstinence of 4 or more years,...

NMDA receptor antagonists distort visual grouping in rats performing a modified two-choice visual discrimination task.

Psychopharmacology October 1, 2013 Katja Clarissa Ward, Halima Zainab Khattak, Louise Richardson et al.

Visual perception is impaired during pathological psychosis, which can be mimicked by NMDA receptor antagonists. However, the underlying mechanisms are poorly understood, partly due to limits of current rodent models for visual integration. The objectives of the study are (1) to develop a rodent task that can differentiate between effects on perception and nonspecific effects on task...

Spicing things up: synthetic cannabinoids.

Psychopharmacology July 9, 2013 Max Spaderna, Peter H. Addy, Deepak Cyril D'Souza

Rationale: Recently, products containing synthetic cannabinoids, collectively referred to as Spice, are increasingly being used recreationally. Objectives: The availability, acute subjective effects-including self-reports posted on Erowid-laboratory detection, addictive potential, and regulatory challenges of the Spice phenomenon are reviewed. Results: Spice is sold under the guise of potpourri...

DOI: 10.1007/s00213-013-3188-4 (opens in new tab) Full text (opens in new tab) Animals Humans Substance-related disorders Cannabinoids +4

Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users

Psychopharmacology June 20, 2013 José Carlos Bouso, Josep María Fábregas, Rosa María Antonijoan et al. 96 citations

BackgroundAyahuasca, a South American psychotropic plant tea containing the psychedelic 5-HT2A receptor agonist N,N-dimethyltryptamine, has been shown to increase regional cerebral blood flow in prefrontal brain regions after acute administration to humans. Despite interactions at this level, neuropsychological studies have not found cognitive deficits in abstinent long-term...

DOI: 10.1007/s00213-013-3167-9 (opens in new tab) Ayahuasca Stroop effect Neuropsychology Cognition +1

Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects.

Psychopharmacology March 1, 2013 Katherine A Maclean, Matthew W Johnson, Chad J Reissig et al. 134 citations

Salvinorin A is a kappa opioid agonist and the principal psychoactive constituent of the plant Salvia divinorum, which has increased in popularity as a recreational drug over the past decade. Few human studies have examined salvinorin A. This double-blind, placebo-controlled study evaluated the dose-related effects of inhaled salvinorin A in individuals with histories of hallucinogen use. Eight...

Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers.

Psychopharmacology March 1, 2013 Lawrence P Carter, Bethea A Kleykamp, Roland R. Griffiths et al. 19 citations

Several studies have documented impairments in memory processes as a result of ketamine administration; however, few studies have compared the profile of cognitive effects of ketamine to other drugs. The aim of this study was to compare the cognitive effects of ketamine with those of triazolam in healthy volunteers. Doses of ketamine (0.2, 0.4 mg/kg intramuscular (i.m.)), triazolam (0.2, 0.4...

DOI: 10.1007/s00213-012-2883-x (opens in new tab) Full text (opens in new tab) Cognitive impairment Memory impairment Cognitive dysfunction Mental decline +28

Cariprazine, a dopamine D(3)-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mouse.

Psychopharmacology March 2013 Ross Zimnisky, Gloria Chang, István Gyertyán et al.

A major challenge in the pharmacological treatment of psychotic disorders is the effective management of the associated cognitive dysfunctions. Novel concepts emphasize a potential benefit of partial agonists acting upon dopamine D(2)-like receptors in ameliorating these cognitive deficits, and pre-clinical studies suggest that D(3)-receptor-preferring compounds can exert pro-cognitive effects....

Discriminative stimulus effects of N,N-diisopropyltryptamine.

Psychopharmacology March 1, 2013 Theresa M. Carbonaro, Michael J Forster, Michael B. Gatch

Serotonergic hallucinogens such as (+)-lysergic acid diethylamide (LSD) and dimethyltryptamine (DMT) produce distinctive visual effects, whereas the synthetic hallucinogen N,N-diisopropyltryptamine (DiPT) is known for its production of auditory distortions. This study compares the discriminative stimulus effects of DiPT to those of visual hallucinogens. Adult male rats were trained to...

Impulsivity, attention, memory, and decision-making among adolescent marijuana users.

Psychopharmacology March 2013 Donald M Dougherty, Charles W Mathias, Michael A Dawes et al.

Marijuana is a popular drug of abuse among adolescents, and they may be uniquely vulnerable to resulting cognitive and behavioral impairments. Previous studies have found impairments among adolescent marijuana users. However, the majority of this research has examined measures individually rather than multiple domains in a single cohesive analysis. This study used a logistic regression model...

Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats.

Psychopharmacology 2013 Tomáš Páleníček, Michaela Fujáková, Martin Brunovský et al. 51 citations

Behavioral, neurochemical and pharmaco-EEG profiles of a new synthetic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats were examined. Locomotor effects, prepulse inhibition (PPI) of acoustic startle reaction (ASR), dopamine and its metabolite levels in nucleus accumbens (NAc), EEG power spectra and coherence in freely moving rats were analysed. Amphetamine was used as a reference...

DOI: 10.1007/s00213-012-2797-7 (opens in new tab) Full text (opens in new tab) 2c-b Synthetic compound Substance Neurotransmitters +18

Effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) and quipazine on heroin self-administration in rhesus monkeys.

Psychopharmacology January 2013 David R Maguire, Jun-Xu Li, Wouter Koek et al.

The serotonin (5-HT) system is involved in pain modulation, and 5-HT receptor agonists can enhance antinociceptive effects of mu opioid receptor agonists. Less is known about the actions of 5-HT receptor agonists on other effects of opioids. This study examined the effects of non-contingent and contingent administration of the 5-HT(2A) receptor agonists DOM and quipazine on i.v. heroin...

Differential involvement of prelimbic and infralimbic medial prefrontal cortex in discrete cue-induced reinstatement of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) seeking in rats.

Psychopharmacology December 1, 2012 Kevin T. Ball, Mylissa Slane

The amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) is a widely abused drug, particularly in adolescent and young adult populations. Although it was shown that MDMA-associated cues reinstate extinguished MDMA seeking in an animal relapse model, there is little information regarding the neural mechanisms underlying this behavior. Because the medial prefrontal cortex...

Acute Effects of THC on Time Perception in Frequent and Infrequent Cannabis Users

Psychopharmacology November 24, 2012 Richard A Sewell, Ashley Schnakenberg, Jacqueline Elander et al.

Cannabinoids have been shown to alter time perception, but existing literature has several limitations. Few studies have included both time estimation and production tasks, few control for subvocal counting, most had small sample sizes, some did not record subjects’ cannabis use, many tested only one dose, and used either oral or inhaled administration of Δ9-tetrahydrocannabinol (THC), leading...

Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking.

Psychopharmacology October 2012 Jane Metrik, Christopher W Kahler, Brady Reynolds et al.

Marijuana is believed to increase impulsivity and risk taking, but the processes whereby it affects such behaviors are not understood. Indeed, either the pharmacologic effect of delta-9-tetrahydrocannabinol (THC) or the expectancy of receiving it may lead to deficits in cognitive processing and increases in risk taking. We examined the relative effects of expecting to receive active marijuana...

High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.

Psychopharmacology September 1, 2012 Chad J Reissig, Lawrence P Carter, Matthew W Johnson et al. 89 citations

Although reports of dextromethorphan (DXM) abuse have increased recently, few studies have examined the effects of high doses of DXM. This study in humans evaluated the effects of supratherapeutic doses of DXM and triazolam. Single, acute oral doses of DXM (100, 200, 300, 400, 500, 600, 700, and 800 mg/70 kg), triazolam (0.25 and 0.5 mg/70 kg), and placebo were administered to 12 healthy...

DOI: 10.1007/s00213-012-2680-6 (opens in new tab) Full text (opens in new tab) Dxm Dextromethorphan Cough suppressant Psychedelic experience +12

Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users.

Psychopharmacology August 2012 Joanna Jacobus, Diane Goldenberg, Christina E Wierenga et al.

The effects of adolescent marijuana use on the developing brain remain unclear, despite its prevalence. Arterial spin labeling (ASL) is a noninvasive imaging technique that characterizes neurovascular status and cerebral blood flow (CBF), potentially revealing contributors to neuropathological alterations. No studies to date have looked at CBF in adolescent marijuana users. This study examined...

Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice

Psychopharmacology July 28, 2012 J. Moreno, Terrell Holloway, Adrienne Umali et al.

In schizophrenia patients, optimal treatment with antipsychotics requires weeks to months of sustained drug therapy. However, single administration of antipsychotic drugs can reverse schizophrenia-like behavioral alterations in rodent models of psychosis. This raises questions about the physiological relevance of such antipsychotic-like activity. This study evaluates the effects of chronic...